The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Euphrosyne Gouzoulis-Mayfrank

Department of Psychiatry and Psychotherapy

University of Cologne



Name/email consistency: high



  • Department of Psychiatry and Psychotherapy, University of Cologne, Germany. 2005 - 2009
  • Department of Psychiatry and Psychotherapy, Medical Faculty of the University of Technology (RWTH), Pauwelsstrasse 30, D-52074 Aachen, Germany. 2003 - 2007


  1. Neurotoxicity of drugs of abuse--the case of methylenedioxyamphetamines (MDMA, ecstasy), and amphetamines. Gouzoulis-Mayfrank, E., Daumann, J. Dialogues. Clin. Neurosci (2009) [Pubmed]
  2. Orienting of attention in unmedicated patients with schizophrenia, prodromal subjects and healthy relatives. Gouzoulis-Mayfrank, E., Balke, M., Hajsamou, S., Ruhrmann, S., Schultze-Lutter, F., Daumann, J., Heekeren, K. Schizophr. Res. (2007) [Pubmed]
  3. Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis. Gouzoulis-Mayfrank, E., Heekeren, K., Neukirch, A., Stoll, M., Stock, C., Daumann, J., Obradovic, M., Kovar, K.A. Neuropsychopharmacology (2006) [Pubmed]
  4. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?. Gouzoulis-Mayfrank, E., Daumann, J. Addiction (2006) [Pubmed]
  5. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview. Gouzoulis-Mayfrank, E., Daumann, J. J. Psychopharmacol. (Oxford) (2006) [Pubmed]
  6. Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use. Gouzoulis-Mayfrank, E., Fischermann, T., Rezk, M., Thimm, B., Hensen, G., Daumann, J. Drug. Alcohol. Depend (2005) [Pubmed]
  7. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers. Gouzoulis-Mayfrank, E., Heekeren, K., Neukirch, A., Stoll, M., Stock, C., Obradovic, M., Kovar, K.A. Pharmacopsychiatry (2005) [Pubmed]
  8. Blunted inhibition of return in schizophrenia-evidence from a longitudinal study. Gouzoulis-Mayfrank, E., Heekeren, K., Voss, T., Moerth, D., Thelen, B., Meincke, U. Prog. Neuropsychopharmacol. Biol. Psychiatry (2004) [Pubmed]
  9. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users. Gouzoulis-Mayfrank, E., Thimm, B., Rezk, M., Hensen, G., Daumann, J. Prog. Neuropsychopharmacol. Biol. Psychiatry (2003) [Pubmed]
  10. Semantic hyperpriming in thought-disordered patients with schizophrenia: state or trait?--a longitudinal investigation. Gouzoulis-Mayfrank, E., Voss, T., Mörth, D., Thelen, B., Spitzer, M., Meincke, U. Schizophr. Res. (2003) [Pubmed]
WikiGenes - Universities